Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Liu, Hao ^a   Shen, Zhenbin ^a   Wang, Zhenglin ^a   Wang, Xuefei ^a   Zhang, Heng ^a   Qin, Jing ^a   Qin, Xinyu ^a   Xu, Jiejie ^a   Sun, Yihong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADENOCARCINOMA; AGED; BIOSYNTHESIS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ENZYMOLOGY; FEMALE; FOLLOW UP; GASTRECTOMY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; STOMACH NEOPLASMS; SURVIVAL RATE;

ADENOCARCINOMA; AGED; BIOMARKERS, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84959036702     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21319     Document Type: Article

References (28)

1. Torre, L. A. et al. Global Cancer Statistics, 2012. CA Cancer J Clin. 65, 87-108 (2015).
2. Mayer, R. J., Venook, A. P., Schilsky, R. L. Progress Against GI Cancer During the American Society of Clinical Oncology's First 50 Years. J Clin Oncol. 32, 1521-1530 (2014).
3. Siegel, R., Ma, J., Zou, Z., Jemal, A. Cancer Statistics, 2014. CA Cancer J Clin. 64, 9-29 (2014).
4. Bass, A. J. et al. Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature. 513, 202-209 (2014).
5. Terentis, A. C. The Heme Environment of Recombinant Human Indoleamine 2,3-Dioxygenase. Structural Properties and Substrate-Ligand Interactions. J Biol Chem. 277, 15788-15794 (2002).
6. Katz, J. B., Muller, A. J., Prendergast, G. C. Indoleamine 2,3-Dioxygenase in T-cell Tolerance and Tumoral Immune Escape. Immunol Rev. 222, 206-221 (2008).
7. Munn, D. H. et al. Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism. J Exp Med. 189, 1363-1372 (1999).
8. Seymour, R. L., Ganapathy, V., Mellor, A. L., Munn, D. H. A High-Affinity, Tryptophan-Selective Amino Acid Transport System in Human Macrophages. J Leukocyte Biol. 80, 1320-1327 (2006).
9. Chiesa, M. D. et al. The Tryptophan Catabolite L-kynurenine Inhibits the Surface Expression of NKp46-and NKG2D-activating Receptors and Regulates NK-cell Function. Blood. 108, 4118-4125 (2006).
10. Astigiano, S. et al. Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non-Small Cell Lung Cancer. Neoplasia. 7, 390-396 (2005).
11. Ferdinande, L. et al. Clinicopathological Significance of Indoleamine 2,3-Dioxygenase 1 Expression in Colorectal Cancer. Brit J Cancer. 106, 141-147 (2011).
12. Brandacher, G. Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect On Tumor-Infiltrating T Cells. Clin Cancer Res. 12, 1144-1151 (2006).
13. Okamoto, A. Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells. Clin Cancer Res. 11, 6030-6039 (2005).
14. Ino, K. et al. Indoleamine 2,3-Dioxygenase is a Novel Prognostic Indicator for Endometrial Cancer. Brit J Cancer. 95, 1555-1561 (2006).
15. Travers, M. T., Gow, I. F., Barber, M. C., Thomson, J., Shennan, D. B. Indoleamine 2,3-Dioxygenase Activity and L-Tryptophan Transport in Human Breast Cancer Cells. BBA-Biomembranes. 1661, 106-112 (2004).
16. Folgiero, V. et al. Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Leukemia Blasts Correlates with Poor Outcome in Childhood Acute Myeloid Leukemia. Oncotarget. 8, 2052-2064 (2014).
17. Cady, S. G., Sono, M. 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (The Oxygen Analog of Tryptophan), and Beta-[3-Benzo(B)thienyl]-DL-alanine (The Sulfur Analog of Tryptophan) are Competitive Inhibitors for Indoleamine 2,3-Dioxygenase. Arch Biochem Biophys. 291, 326-333 (1991).
18. Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., Prendergast, G. C. Inhibition of Indoleamine 2,3-Dioxygenase, an Immunoregulatory Target of the Cancer Suppression Gene Bin1, Potentiates Cancer Chemotherapy. Nat Med. 11, 312-319 (2005).
19. Larussa, T. et al. Enhanced Expression of Indoleamine 2,3-Dioxygenase in Helicobacter Pylori-Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production. Helicobacter. 1, 41-48 (2015).
20. Kim, J. W. et al. Prognostic Implications of Immunosuppressive Protein Expression in Tumors as Well as Immune Cell Infiltration within the Tumor Microenvironment in Gastric Cancer. Gastric Cancer, doi: 10. 1007/s10120-014-0440-5 (2014).
21. Zhang, R. P. et al. The Correlation Between the Subsets of Tumor Infiltrating Memory T Cells and the Expression of Indoleamine 2,3-Dioxygenase in Gastric Cancer. Digest Dis Sci. 58, 3494-3502 (2013).
22. Schreiber, R. D., Old, L. J., Smyth, M. J. Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion. Science. 331, 1565-1570 (2011).
23. Edinger, A. L., Thompson, C. B. Antigen-Presenting Cells Control T Cell Proliferation by Regulating Amino Acid Availability. P Nalt Acad Sci USA 99, 1107-1109 (2002).
24. Fallarino, F. et al. The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor Zeta-Chain and Induce a Regulatory Phenotype in Naive T Cells. J Immunol. 176, 6752-6761 (2006).
25. Smith, C. et al. IDO is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development. Cancer Discov. 2, 722-735 (2012).
26. Francois, M., Romieu-Mourez, Li, M., Galipeau, J. Human MSC Suppression Correlates with Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation. Mol Ther. 1, 187-195 (2012).
27. Zhang, H. et al. Infiltration of Diametrically Polarized Macrophages Predicts Overall Survival of Patients with Gastric Cancer After Surgical Resection. Gastric Cancer. 18, 740-50 (2014).
28. Camp, R. L., Dolled-Filhart, M., Rimm, D. L. X-Tile: A New Bio-Informatics Tool for Biomarker Assessment and Outcome-Based Cut-Point Optimization. Clin Cancer Res. 10, 7252-7259 (2004).